- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Vivus Inc+ Add to Watchlist
VVUS:US9.9700 USD 0.5100 5.39%
As of 14:13:34 ET on 12/12/2013.
Company Profile for Vivus Inc (VVUS)
VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
Key Executives for Vivus Inc (VVUS)
|Seth H Z FischerChief Executive Officer||Timothy E MorrisSenior VP:Finance/CFO|
|Michael P Miller "Mike"Senior VP/Chief Commercial Ofcr||Lee B PerryVP/Chief Acctg Ofcr/Assistant Secy|
|John L SlebirVP:Bus Dev/Secy/General Cnsl||Guy P MarshVP:US Ops/General Manager|
|Wesley W DayVP:Clinical Development|